• 四川大學(xué)華西醫(yī)院普外科（成都610041）;

【摘要】目的 介紹肝移植治療肝泡狀棘球蚴?。ˋHD）的臨床進(jìn)展。
方法復(fù)習(xí)文獻(xiàn)，綜述國(guó)內(nèi)、外最新研究與治療進(jìn)展。
結(jié)果肝移植治療晚期肝AHD的5年生存率達(dá)71%，術(shù)中切除病肝和術(shù)后避免復(fù)發(fā)是治療的主要難題。
結(jié)論肝移植是目前惟一有效而又可行的能治愈肝AHD的方法，值得進(jìn)一步探討推廣。

引用本文： 夏天,嚴(yán)律南. 肝移植治療肝泡狀棘球蚴病. 中國(guó)普外基礎(chǔ)與臨床雜志, 2005, 12(2): 132-134. doi: 復(fù)制

1. Gillet M, Miguet JP, Mantion G, et al. Orthotopic liver transplantation in alveolar echinococcosis of the liver: analysis of a series of six patients [J]. Transplant Proc, 1988; 20(1 Suppl 1)573.
2. Koch S, BressonHadni S, Miguet JP, et al. Experience of liver transplantation for incurable alveolar echinococcosis: a 45case European collaborative report [J]. Transplantation, 2003; 75(6)856.
3. 溫浩，欒梅香，王希艷，等. 國(guó)內(nèi)首例肝移植治療肝泡型包蟲(chóng)病報(bào)告 [J]. 地方病通報(bào)， 2001； 16（3）100.
4. 嚴(yán)律南，李波，盧實(shí)春， 等. 同種原位異體肝移植治療晚期肝包蟲(chóng)病 [J]. 中國(guó)普外基礎(chǔ)與臨床雜志， 2002； 9（1）28.
5. Suter M, Gillet M. Liver Transplantation in Alveolar Hydatid Disease [J]. Dig Surg, 1997; 14(2)229.
6. BressonHadni S, Franza A, Miguet JP, et al. Orthotopic liver transplantation for incurable alveolar echinococcosis of the liver: report of 17 cases [J]. Hepatology, 1991; 13(6)1061.
7. Chapuis Y, Houssin D, Brouzes S, et al. Hepatic transplantation in alveolar echinococcosis. 3 attempts [J]. Chirurgie, 1987; 113(6)634.
8. Shaw BW Jr, Iwatsuki S, Bron K, et al. Portal vein grafts in hepatic transplantation [J]. Surg Gynecol Obstet, 1985; 161(1)66.
9. Bout D, Deslee D, Capron A. Antischistosomal effect of cyclosporin A: cure and prevention of mouse and rat schistosomiasis mansoni [J]. Infect Immun, 1986; 52(3)823.
10. Bout D, Haque A, Capron A. Filaricidal effects of cyclosporinA against Dipetalonema viteae in Mastomys natalensis [J]. Trans R Soc Trop Med Hyg, 1984; 78(5)670.
11. Liance M, BressonHadni S, Vuitton DA, et al. Effects of cyclosporin A on the course of murine alveolar echinococcosis and on specific cellular and humoral immune responses against Echinococcus multilocularis [J]. Int J Parasitol, 1992; 22(1)23.
12. Adam R, Cailliez V, Majno P, et al. Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study [J]. Lancet， 2000; 356(9230)621.
  1. 1. Gillet M, Miguet JP, Mantion G, et al. Orthotopic liver transplantation in alveolar echinococcosis of the liver: analysis of a series of six patients [J]. Transplant Proc, 1988; 20(1 Suppl 1)573.
  2. 2. Koch S, BressonHadni S, Miguet JP, et al. Experience of liver transplantation for incurable alveolar echinococcosis: a 45case European collaborative report [J]. Transplantation, 2003; 75(6)856.
  3. 3. 溫浩，欒梅香，王希艷，等. 國(guó)內(nèi)首例肝移植治療肝泡型包蟲(chóng)病報(bào)告 [J]. 地方病通報(bào)， 2001； 16（3）100.
  4. 4. 嚴(yán)律南，李波，盧實(shí)春， 等. 同種原位異體肝移植治療晚期肝包蟲(chóng)病 [J]. 中國(guó)普外基礎(chǔ)與臨床雜志， 2002； 9（1）28.
  5. 5. Suter M, Gillet M. Liver Transplantation in Alveolar Hydatid Disease [J]. Dig Surg, 1997; 14(2)229.
  6. 6. BressonHadni S, Franza A, Miguet JP, et al. Orthotopic liver transplantation for incurable alveolar echinococcosis of the liver: report of 17 cases [J]. Hepatology, 1991; 13(6)1061.
  7. 7. Chapuis Y, Houssin D, Brouzes S, et al. Hepatic transplantation in alveolar echinococcosis. 3 attempts [J]. Chirurgie, 1987; 113(6)634.
  8. 8. Shaw BW Jr, Iwatsuki S, Bron K, et al. Portal vein grafts in hepatic transplantation [J]. Surg Gynecol Obstet, 1985; 161(1)66.
  9. 9. Bout D, Deslee D, Capron A. Antischistosomal effect of cyclosporin A: cure and prevention of mouse and rat schistosomiasis mansoni [J]. Infect Immun, 1986; 52(3)823.
  10. 10. Bout D, Haque A, Capron A. Filaricidal effects of cyclosporinA against Dipetalonema viteae in Mastomys natalensis [J]. Trans R Soc Trop Med Hyg, 1984; 78(5)670.
  11. 11. Liance M, BressonHadni S, Vuitton DA, et al. Effects of cyclosporin A on the course of murine alveolar echinococcosis and on specific cellular and humoral immune responses against Echinococcus multilocularis [J]. Int J Parasitol, 1992; 22(1)23.
  12. 12. Adam R, Cailliez V, Majno P, et al. Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study [J]. Lancet， 2000; 356(9230)621.